Moderna: Comeback thanks to AI? According to Oracle CEO Ellison, cancer vaccines could be developed within 48 hours.

For the mRNA specialist Moderna (MRNA), the Corona pandemic was a significant time. As the pandemic subsided, demand plummeted. At least they have now also released an RSV vaccine to diversify their revenue goals. The next big thing is likely to be cancer vaccines, such as those for skin cancer. By 2025, there is a chance to release a personalized cancer vaccine for melanoma through an accelerated approval process. According to the latest shareholder letter, ten new products are expected to hit the market by 2027. Moderna claims to have the largest...